Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 Years after introduction of sugammadex: Changes in opinions and clinical practice

Anesthesiology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Ledowski, Thomas ^a,b   Ong, Jing Shen ^a   Flett, Tom ^c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; SUGAMMADEX;

ADOLESCENT; ADULT; AGED; ANESTHESIST; ARTICLE; CLINICAL PRACTICE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MEDICAL AUDIT; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TEACHING HOSPITAL; TERTIARY CARE CENTER;

EID: 84932599313     PISSN: 16876962     EISSN: 16876970     Source Type: Journal    
DOI: 10.1155/2015/367937     Document Type: Article

References (11)

1. T. Ledowski, S. Hillyard, A. Kozman et al., "Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs," Anaesthesia and Intensive Care, vol. 40, no. 2, pp. 340-343, 2012.
2. T. Ledowski, S. Hillyard, B. O'Dea, R. Archer, B. Vilas-Boas, and B. Kyle, "Introduction of sugammadex as standard reversal agent: impact on the incidence of residual neuromuscular blockade and postoperative patient outcome," Indian Journal of Anaesthesia, vol. 57, no. 1, pp. 46-51, 2013.
3. M. King, N. Sujirattanawimol, D. R. Danielson, B. A. Hall, D. R. Schroeder, and D. O. Warner, "Requirements for muscle relaxants during radical retropubic prostatectomy," Anesthesiology, vol. 93, no. 6, pp. 1392-1397, 2000.
4. C. H. Martini, M. Boon, R. F. Bevers, L. P. Aarts, A. Dahan, and J. P. Thompson, "Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block," British Journal of Anaesthesia, vol. 112, no. 3, pp. 498-505, 2014.
5. P. E. Dubois, L. Putz, J. Jamart, M.-L.Marotta,M. Gourdin, and O.Donnez, "Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy," European Journal of Anaesthesiology, vol. 31, no. 8, pp. 430-436, 2014.
6. A. K. Staehr-Rye, L. S. Rasmussen, J. Rosenberg et al., "Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study," Anesthesia & Analgesia, vol. 119, no. 5, pp. 1084-1092, 2014.
7. K. Leslie, P. S. Myles, A. Forbes, and M. T. V. Chan, "The effect of bispectral index monitoring on long-term survival in the Baware trial," Anesthesia and Analgesia, vol. 110, no. 3, pp. 816- 822, 2010.
8. M. Naguib, A. F. Kopman, C. A. Lien, J.M. Hunter, A. Lopez, and S. J. Brull, "A survey of current management of neuromuscular block in the United States and Europe," Anesthesia and Analgesia, vol. 111, no. 1, pp. 110-119, 2010.
9. S. J. Brull and G. S. Murphy, "Residual neuromuscular block: lessons unlearned. Part ii:methods to reduce the risk of residual weakness," Anesthesia and Analgesia, vol. 111, no. 1, pp. 129-140, 2010.
10. Y. Kotake, R. Ochiai, T. Suzuki et al., "Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block," Anesthesia and Analgesia, vol. 117, no. 2, pp. 345-351, 2013.
11. T. Fuchs-Buder, "Less is not always more: sugammadex and the risk of under-dosing," European Journal of Anaesthesiology, vol. 27, no. 10, pp. 849-850, 2010.